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Cloning, Science and Public Policy
transcribedremarks of
SENATOR DEBORAH ORTIZ*

Let me give you a little bit of personal background on why I
became interested in this issue. As was mentioned in my bio, I am the
chair of the Senate Health and Human Services Committee. I really
enjoy dealing with the very complex issue of access to health care and
have a history of interest in medical care system costs for long-term,
chronic diseases-specifically things like cancer.
I got involved with the issue of cancer research when I was in the
State Assembly and authored a piece of legislation to fund $25
million per year for gender-based cancer research. Unfortunately,
that funding is subject to the annual appropriation of our general
fund. For three years, we were able to appropriate a lot of dollars
from the general fund into prostrate and ovarian cancer research. I
have a particular interest in this area because my mother died from
ovarian cancer. This year, we are struggling with the state budget.
There has been an effort, which we dealt with a couple of days ago, to
take $10 or $15 million out of the $25 million that had already been
given to researchers who are in the midst of research projects. This
effort, in fact, called for not funding some of the projects that already
have received funding. So I certainly have a personal, scientific and
policy interest in how we tackle the cost of our health care system
over time, particularly as it relates to chronic disease. I've looked at
stem cell research as a way of addressing this very important policy
issue. Politicians, believe it or not, actually do love public policy.
This area poses a fascinating combination of not only legal issues but
ethical, medical and scientific issues as well. It was an area in which I
knew I would want to be involved.
My bio failed to mention that I am a graduate of McGeorge
School of Law. (I was wait-listed here at Hastings, and I'll have to
talk to someone before I leave about not getting in.) I was fortunate
enough to take Constitutional Law from Justice Kennedy. I recall
very clearly his analysis of Roe v. Wade' and his dependence on the
* California State Senator (Democrat, Sacramento).
1. 410 U.S. 113 (1973).
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first trimester and the absolute right to privacy of a woman to make
that decision on her own. I am hoping that we can hang our hat on
his reasoning and on the First Amendment arguments posed by the
previous speaker. I also think that there is a possibility of making out
an interstate commerce clause argument, although I won't talk about
that now.
Having given you a bit of background, let me also tell you why I
feel strongly about California stepping out and being a leader in this
area. I happen to be a politician who absolutely believes in the hope
of political advocacy and policy making. But I also know the
limitations of politicians making policy. As chair of the Senate
Health and Human Services Committee, I am often approached by
one special interest group or another. In one recent incident, a group
was trying to push a mandatory Hepatitis A vaccination for every
child before they enter elementary school. This might not seem like a
complex policy question. Either the science says you need it or you
don't. But it wasn't that clear, so we spent three-and-a-half hours on
whether or not the medical community agrees on a very expensiveand some will argue unnecessary-means of protecting people against
Hepatitis B and C as adults and not necessarily Hepatitis A in
children.
I love the area of stem cell research. I am reading everything I
can get my hands on and I welcome the debate from both sides of the
legal argument. But I also know the limitations of politicians who do
not work in this area every day. As a result, I am convening a task
force of the legal minds, the scientific minds and the ethicists in this
area to help guide California's policy. Absent that kind of leadership,
we will continue to make imperfect policy. The ban on reproductive
cloning may in fact be one of those political decisions and legislative
acts that, in the future, will not withstand the information developed
in the scientific and medical community.
I look at therapeutic stem cell research as something that is
incredibly promising. It is something that I believe we have an
obligation to allow as a legislature. But let me talk a bit about the
limitations of a legislative or political decision to move forward on
therapeutic stem cell research.
California is viewed as this
wonderfully progressive and liberal state. The reality is, it is not. We
have a very divided state. Politicians differ on just the simple
question of whether or not a woman has a right to choose. I think it is
an absolute right. But if you've ever sat in on a health committee
hearing on something as basic as public funding for poor or
undocumented women's access to health care, you'd understand how
close we are as a legislative body to some very arcane and backward
decisions. This issue, of course, is very much like that.
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I think the question of therapeutic, or non-reproductive, stem
cell research is very clear. But I've seen the debate that ensued in the
committee that presented its report to the legislature. I have
witnessed discussions in which people disagreed on even the value of
non-reproductive therapeutic cloning. Politicians like myself and
others will have to be very vigilant, not about the science or the logic,
but about the political implications of those who fiercely believe that
we ought not to be engaging in therapeutic stem cell research. It is a
battle and it is a challenge. I am committed to showing my colleagues
two things: number one, that California believes that the Bush line of
stem cell research is limited; and number two, that there is a role for
the public funding of research. It's going to take careful maneuvering
and constant effort to battle those ethical arguments against
therapeutic research, which many of us believe are unfounded.
The fact that the committee recommended, based on primarily
scientific reasons, to ban reproductive cloning in California is not
without controversy. However, I suspect the controversy of lifting
that ban or leaving that question open would have caused greater
problems. There is a very entrenched, very difficult part of our
constituency which is uncomfortable with this area. Quite frankly,
this segment is not strictly partisan. There are Democrats-and I am
a Democrat-who are also very uncomfortable with drawing the line
and who may in fact be very uncomfortable with my efforts to allow
public funding of therapeutic research. So, let me say that as we face
these ethical quandaries, there are also very real political quandaries.
Politicians often operate in a sort of system in which we try to
incrementally do good, or incrementally do no harm. I do believe
that it's going to be a battle for California to make a commitment to
therapeutic stem cell research and to fund that with public dollars.
But it's a battle that we have to embark upon. It's critical.
I do believe that we will suffer in California, if in fact Congress is
successful in banning various types of research beyond what the
President has done to date. I fear that California will suffer the kind
of brain drain that we are beginning to see. We are uniquely situated
with some of the brightest minds and institutions in the biotech
industry to innovate, to cure disease and to bring down the cost of
health care. We have a responsibility to take on this battle so that the
rest of the states will hopefully look to us for some direction.
The precedent for public funding of research is very strong in our
country. It has fueled the development of our semi-conductor
industry. It has played a role in the development of the aerospace
industry and the human genome project. Some of my colleagues will
say it is not the government's place to fund this. But in fact,
government has often funded research and but for that public
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funding, we wouldn't have the innovation and success in key areas of
science and medicine that we have today.
What is the relationship of private entities to public funding?
Private entities, I believe, play a very critical role in translating the
fruits of publicly-funded research into effective medical therapies. I
think that a partnership should be developed within some parameters.
I believe if we are indeed successful in moving forward with public
funding, we will see innovation in therapeutic stem cell research. I'd
prefer that it happen in the open, that it be open to public scrutiny
and that there be some sunshine on that research. That would be the
responsibility of those private entities that want those public dollars.
It is going to be a huge challenge to educate the average person
on the value of this research. I think many people who have family
members who are suffering from disease will understand this. I think
that most Californians, ultimately, will want to do the right thing to
save lives and to prevent suffering. And in the end, I always like to
make the fiscal argument. This is key to where we are going in our
health care system in general, as we negotiate the scope of health care
coverage for persons who are covered, and as we fight to get health
insurance for those who don't have health insurance in California.
Bush's limitations are pretty intriguing They actually created a
division in the anti-choice community. And I point that out because I
think we have to remember how important the politics are to this
issue. The fact that very active anti-choice politicians, legislators and
key people in the anti-choice movement divide on this question is a
good thing. I think there needs to be more debate in the anti-choice
community and among politicians. This suggests to me that there is
an opportunity to form religious and inter-faith alliances on behalf of
therapeutic stem cell research. There is much data to suggest that the
limitations imposed by the Bush administration could sound the
death knell for the research if we stop at that point. We also have a
concern with the genetic biodiversity of those stem cell lines. Are
they all white, middle class embryos? Does that reflect California?
We need genetic diversity and there are some who suggest that it's
not available in those lines. There is a concern that even with access
to the sixty or sixty-four lines, assuming that they are all viable, could
the public actually access those that are owned or held by private
companies given the surrounding intellectual property questions?
Are they obligated to share those and if so, will they share them only
with the highest bidders? So even if all the available lines are good,

2. In late 2001 President Bush decided to allow federal funding of research using sixty
existing stem cell lines derived from human embryos. The President declined to allow
federal funding for research using stem cells derived from frozen embryos.

July 2002]

CLONING, SCIENCE AND PUBLIC POLICY

usable and would be sound for research, the public may have other
impediments before it could access them.
Let me talk a bit about the legislation. My colleague, Senator
Dede Alpert, has introduced a bill to continue the current ban on
reproductive cloning that is set to end in 2002. I believe that she is
striking the sunset that is proposed. In effect, that would mean that if
this bill reaches the Governor's desk and is signed, it would
indefinitely ban reproductive cloning. I have two measures, one of
which is resolution SCR 55. It essentially establishes a panel to guide
the legislature as we move forward in publicly-funded-I hopetherapeutic stem cell research. It assures that there will be scientists,
specialists, ethicists and lawyers guiding the legislature
and
preventing whatever harm politicians might do while making policy.
The other bill is SB 1272. At this point, it is an outline for moving
forward on research. Essentially, it would allow that research to
occur in California. It would allow a woman to donate embryos with
some requirements. It would also prohibit the sale or purchase of
embryos for research. It is just a basic outline and I don't think there
is much debate on what is in there now. It really serves as a
foundation to begin the discussion in California.
This year, I hoped to look at a means for public funding. Given
the budget situation, that is going to be very difficult. We're probably
going to have a $12.5 billion deficit and right now, we're simply
fighting to hold on to some basic safety net health care systems. I've
made that my battle, particularly for the working poor in California
who don't have health care. My hope-and hopefully I'll be reelected this year to have four more years to pursue it-is that
somewhere down the line, like infrastructure for freeways, highways
and roads, we will invest, as a state, in human and scientific
infrastructure. We need to provide ongoing and risk-free sources of
funding that are built into our state budget to continually fund
research like this. With the cancer research funding of $25 million
subject to annual appropriation, my experience is that in a year like
this year, those dollars will be quickly taken away. It sends the worst
message to the brightest minds that they cannot rely on California for
a long-term commitment to research.
I would like to take a bond measure to the voters statewide and
ask them whether they would support a permanent source of funding
for our infrastructure on research-particularly on stem cells. It will
probably have a bit more momentum in two or three years. I believe
that the average voter will say this is the right thing to do. We could
say to researchers across the country and across the world: "Come to
California. We will fund you for a long period of time." As most
people know, researchers don't achieve success in a year or two.
That, I believe, is the obligation we owe to all Californians. I also
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believe that this research really does hold the key to curing disease,
injury, and to long-term medical problems. Based on the cost and the
inequities and disparities in our health care system, it is the right thing
to do.
We are going to have the first of a series of informational
hearings on stem cell research and the taskforce I'm forming on
March 8, 2002, at Stanford University. We will begin to look more
closely at the limitations in the Bush position and the potential in
California to go beyond that. With that, I thank you for inviting me.
Thank you.

